Longevity Report · Week of July 11, 2026
Frailty defenses, dose debates, biological-age biomarkers, circadian medicine, and rest-state science
- Minimal-Dose Exercise Versus Optimal Guidelines: How Much Movement Actually Protects Aging BodiesThree seconds a day. Four minutes a day. Five minutes a day. Forget your step count—speed, not steps. Every headline this week promises the same thing: that the price of protecting an aging body has collapsed to somethin…
- Coupled Decline: Mapping the Shared Biology of Muscle, Bone, and Cognitive AgingArticle — "Coupled Decline: Mapping the Shared Biology of Muscle, Bone, and Cognitive Aging": Article — "Coupled Decline: Mapping the Shared Biology of Muscle, Bone, and Cognitive Aging": Nearly a third of the proteins l…
- Circadian Medicine Moves Toward the Clinic: Timing Vaccines, Drugs, and Light TherapyArticle — "Circadian Medicine Moves Toward the Clinic: Timing Vaccines, Drugs, and Light Therapy": Article — "Circadian Medicine Moves Toward the Clinic: Timing Vaccines, Drugs, and Light Therapy": At day 28 after a four…
- Biological-Age Clocks Meet Depression and Metabolic Risk in Aging CohortsIn the biologically oldest quartile of NHANES adults, depression risk was 45% lower — not higher — than in the quartile just below it (OR = 0.55, 95% CI 0.49–0.63).
- Beyond Sleep: The Contested Science of Rest States, Sleep Inertia, and Dietary Sleep AidsHere is a contradiction worth sitting with: the most famous "beyond sleep" practice of the moment—non-sleep deep rest, sold as a science-backed recovery tool—reportedly has run essentially no controlled outcome trials, w…
Threads we are following
- The San-Millan muscle-biopsy mechanism for 'healthy sedentary' as bioenergetic downshift, flagged for a future issue
- Whether MASS_Lifecourse biopsy data can finally establish temporal order between inflammation and muscle loss
- Will larger, sex-stratified randomized trials confirm the morning-vaccination antibody boost beyond the single Melbourne Moderna signal?
- Whether treating depression prospectively reverses proteomic aging markers in a controlled trial, not just observational remission data
- Will a larger, non-pregnant double-blind trial replicate the lettuce-seed sleep benefit and establish dosing?
One issue a week. Free.
sift. reads hundreds of sources so you don't have to, and sends one issue you can actually finish. No daily noise. Unsubscribe anytime.